Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer

NCT03233555 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 535

Last updated 2022-08-29

No results posted yet for this study

Summary

This study tests four different methods of educating patients about follow-up care (NCI facing forward, brochure, EXCELS website alone, EXCELS health coaching alone and EXCELS website \& health coaching combination) after cancer treatment ends. While it is known that patients need information to guide follow-up it remains unknown how to best provide this in primary care.

Conditions

  • Stage I Breast Cancer
  • Stage I Colorectal Cancer AJCC v6 and v7
  • Stage I Prostate Cancer
  • Stage IA Breast Cancer
  • Stage IB Breast Cancer
  • Stage II Breast Cancer
  • Stage II Colorectal Cancer AJCC v7
  • Stage II Prostate Cancer
  • Stage IIA Breast Cancer
  • Stage IIA Colorectal Cancer AJCC v7
  • Stage IIA Prostate Cancer
  • Stage IIB Breast Cancer
  • Stage IIB Colorectal Cancer AJCC v7
  • Stage IIB Prostate Cancer
  • Stage IIC Colorectal Cancer AJCC v7
  • Stage III Colorectal Cancer AJCC v7
  • Stage IIIA Colorectal Cancer AJCC v7
  • Stage IIIB Colorectal Cancer AJCC v7
  • Stage IIIC Colorectal Cancer AJCC v7

Interventions

OTHER

Informational Intervention

Receive brochure

OTHER

Internet-Based Intervention

Have access to EXCELS

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

BEHAVIORAL

Telephone-Based Intervention

Receive quarterly calls

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • National Institutes of Health (NIH)

    collaborator NIH
  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Shawna Hudson · Rutgers Cancer Institute of New Jersey

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-03
Primary Completion
2020-01-15
Completion
2022-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03233555 on ClinicalTrials.gov